{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:30:36Z","timestamp":1774895436882,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44GM122196-02A1"],"award-info":[{"award-number":["R44GM122196-02A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["440773\/2019-8"],"award-info":[{"award-number":["440773\/2019-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R42AT01585-01"],"award-info":[{"award-number":["1R42AT01585-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000935","name":"Russell Sage Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/07600-3"],"award-info":[{"award-number":["2013\/07600-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/05130-3"],"award-info":[{"award-number":["2018\/05130-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bmc.2023.117239","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T12:44:54Z","timestamp":1678884294000},"page":"117239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1456-8882","authenticated-orcid":false,"given":"Ana C.","family":"Puhl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela S.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre S.","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura H.V.G.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glaucius","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Ekins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117239_b0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0035-9203(57)90022-6","article-title":"An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952\u201353; an additional note on Chikungunya virus isolations and serum antibodies","volume":"51","author":"Mason","year":"1957","journal-title":"Trans Roy Soc Trop Med Hygiene"},{"key":"10.1016\/j.bmc.2023.117239_b0010","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1371\/journal.pmed.0030263","article-title":"Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak","volume":"3","author":"Schuffenecker","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.bmc.2023.117239_b0015","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3201\/eid1403.070906","article-title":"Chikungunya fever in travelers returning to Europe from the Indian Ocean region","volume":"14","author":"Panning","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bmc.2023.117239_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2017.03.006","article-title":"Global expansion of chikungunya virus: mapping the 64-year history","volume":"58","author":"Wahid","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bmc.2023.117239_b0025","unstructured":"N. Rodrigues Faria, J. Louren\u00e7o, E. Marques de Cerqueira, M. Maia de Lima, O. Pybus, L. Carlos Junior Alcantara, Epidemiology of Chikungunya Virus in Bahia, Brazil, 2014-2015, PLoS Curr, 8 (2016)."},{"key":"10.1016\/j.bmc.2023.117239_b0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.actatropica.2018.09.003","article-title":"A scoping review of Chikungunya virus infection: epidemiology, clinical characteristics, viral co-circulation complications, and control","volume":"188","author":"Silva","year":"2018","journal-title":"Acta Trop"},{"key":"10.1016\/j.bmc.2023.117239_b0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijid.2018.02.007","article-title":"Potential risks of Zika and chikungunya outbreaks in Brazil: A modeling study","volume":"70","author":"Aguiar","year":"2018","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bmc.2023.117239_b0040","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.3390\/v6114628","article-title":"Chikungunya virus-vector interactions","volume":"6","author":"Coffey","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2023.117239_b0045","first-page":"134","article-title":"Arboviruses and pregnancy: maternal, fetal, and neonatal effects, Lancet Child Adolesc","volume":"1","author":"Charlier","year":"2017","journal-title":"Health"},{"key":"10.1016\/j.bmc.2023.117239_b0050","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1586\/erv.12.84","article-title":"Chikungunya virus and prospects for a vaccine","volume":"11","author":"Weaver","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.bmc.2023.117239_b0055","first-page":"e107","article-title":"Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen, The Lancet","volume":"17","author":"Burt","year":"2017","journal-title":"Infect Dis"},{"key":"10.1016\/j.bmc.2023.117239_b0060","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI84417","article-title":"Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies","volume":"127","author":"Silva","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2023.117239_b0065","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.idc.2019.08.006","article-title":"Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention","volume":"33","author":"Vairo","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.bmc.2023.117239_b0070","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI40104","article-title":"Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages","volume":"120","author":"Labadie","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2023.117239_b0075","doi-asserted-by":"crossref","first-page":"e1446","DOI":"10.1371\/journal.pntd.0001446","article-title":"Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia","volume":"6","author":"Dupuis-Maguiraga","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2023.117239_b0080","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.drudis.2013.05.002","article-title":"Chikungunya virus: an update on antiviral development and challenges","volume":"18","author":"Kaur","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2023.117239_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.618624","article-title":"Current and Promising Antivirals Against Chikungunya Virus","volume":"8","author":"Hucke","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.bmc.2023.117239_b0090","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/acsinfecdis.0c00915","article-title":"Discovery of a Potent and Selective Chikungunya Virus Envelope Protein Inhibitor through Computer-Aided Drug Design","volume":"7","author":"Battini","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2023.117239_b0095","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1021\/acs.jmedchem.0c02183","article-title":"Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors","volume":"64","author":"Ahmed","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117239_b0100","doi-asserted-by":"crossref","first-page":"e0245013","DOI":"10.1371\/journal.pone.0245013","article-title":"Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design","volume":"16","author":"Zhang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117239_b0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bmc.2016.10.037","article-title":"Discovery of novel multi-target indole-based derivatives as potent and selective inhibitors of chikungunya virus replication","volume":"25","author":"Scuotto","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117239_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126881","article-title":"Quinolone-N-acylhydrazone hybrids as potent Zika and Chikungunya virus inhibitors","volume":"30","author":"Marra","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117239_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/v14071351","article-title":"The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication","volume":"14","author":"Policastro","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2023.117239_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11095-020-02799-8","article-title":"Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond","volume":"37","author":"Ekins","year":"2020","journal-title":"Pharm Res"},{"key":"10.1016\/j.bmc.2023.117239_b0125","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00649-20","article-title":"Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery","volume":"64","author":"Abdelnabi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117239_b0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.antiviral.2018.03.013","article-title":"Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme","volume":"154","author":"Feibelman","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2023.117239_b0135","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1021\/acsomega.1c00625","article-title":"Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation, ACS","volume":"6","author":"Ivanova","year":"2021","journal-title":"Omega"},{"key":"10.1016\/j.bmc.2023.117239_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/v13071307","article-title":"Antivirals against the Chikungunya Virus","volume":"13","author":"Battisti","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2023.117239_b0145","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01788-20","article-title":"Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance","volume":"64","author":"Kovacikova","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117239_b0150","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1021\/acs.jcim.2c00596","article-title":"Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika","volume":"62","author":"Mottin","year":"2022","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2023.117239_b0155","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2023.117239_b0160","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1021\/acs.molpharmaceut.2c00662","article-title":"Machine Learning Models Identify New Inhibitors for Human OATP1B1","volume":"19","author":"Lane","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2023.117239_b0165","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1021\/acs.molpharmaceut.1c00791","article-title":"Machine Learning Models for","volume":"19","author":"Lane","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2023.117239_b0170","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1021\/acs.molpharmaceut.0c00326","article-title":"Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury","volume":"17","author":"Minerali","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2023.117239_b0175","article-title":"Molecular Epidemiology","volume":"12","author":"Sharif","year":"2021","journal-title":"Evolution and Reemergence of Chikungunya Virus in South Asia, Front Microbiol"},{"key":"10.1016\/j.bmc.2023.117239_b0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.antiviral.2015.07.002","article-title":"Chikungunya virus pathogenesis: From bedside to bench","volume":"121","author":"Couderc","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2023.117239_b0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.antiviral.2013.06.009","article-title":"Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy","volume":"99","author":"Thiberville","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2023.117239_b0190","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.meegid.2016.04.006","article-title":"Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review","volume":"41","author":"Lo Presti","year":"2016","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.bmc.2023.117239_b0195","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117239_b0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/cmdc.201700629","article-title":"Discovery and Mechanistic Elucidation of a Class of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma","volume":"13","author":"Kyani","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117239_b0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drudis.2013.10.017","article-title":"Protein disulfide isomerase: a promising target for cancer therapy","volume":"19","author":"Xu","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2023.117239_b0210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/cb100387r","article-title":"Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120","volume":"6","author":"Khan","year":"2011","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2023.117239_b0215","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.antiviral.2017.04.014","article-title":"Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential","volume":"143","author":"Langsjoen","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2023.117239_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/v11020155","article-title":"Protein Disulfide Isomerase Inhibitor Suppresses Viral Replication and Production during Antibody-Dependent Enhancement of Dengue Virus Infection in Human Monocytic Cells","volume":"11","author":"Rawarak","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2023.117239_b0225","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2012209118","article-title":"Small-molecule endoplasmic reticulum proteostasis regulator acts as a broad-spectrum inhibitor of dengue and Zika virus infections","volume":"118","author":"Almasy","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117239_b0230","doi-asserted-by":"crossref","first-page":"17227","DOI":"10.1021\/acsomega.8b02676","article-title":"Gene Expression Profiling of Endoplasmic Reticulum Stress in Hepatitis C Virus-Containing Cells Treated with an Inhibitor of Protein Disulfide Isomerases","volume":"3","author":"Ozcelik","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2023.117239_b0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.virusres.2018.01.010","article-title":"Protein disulfide isomerases as potential therapeutic targets for influenza A and B viruses","volume":"247","author":"Kim","year":"2018","journal-title":"Virus Res"},{"key":"10.1016\/j.bmc.2023.117239_b0240","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00705-013-1626-6","article-title":"Implication of Hsc70, PDI and integrin alphavbeta3 involvement during entry of the murine rotavirus ECwt into small-intestinal villi of suckling mice","volume":"158","author":"Santana","year":"2013","journal-title":"Arch Virol"},{"key":"10.1016\/j.bmc.2023.117239_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/v13010053","article-title":"Protein Disulfide Isomerase A4 Is Involved in Genome Uncoating during Human Astrovirus Cell Entry","volume":"13","author":"Aguilar-Hernandez","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2023.117239_b0250","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/ci010132r","article-title":"Reoptimization of MDL keys for use in drug discovery","volume":"42","author":"Durant","year":"2002","journal-title":"J Chem Inf Comput Sci"},{"key":"10.1016\/j.bmc.2023.117239_b0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2015.12.012","article-title":"Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses","volume":"126","author":"Varghese","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2023.117239_b0260","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1128\/JVI.01382-16","article-title":"The antiviral alkaloid berberine reduces chikungunya virus-induced mitogen-activated protein kinase signaling","volume":"90","author":"Varghese","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2023.117239_b0265","doi-asserted-by":"crossref","first-page":"11320","DOI":"10.1038\/ncomms11320","article-title":"A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs","volume":"7","author":"Karlas","year":"2016","journal-title":"Nature Comm"},{"key":"10.1016\/j.bmc.2023.117239_b0270","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1128\/AAC.01675-12","article-title":"A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia","volume":"57","author":"Tejman-Yarden","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117239_b0275","doi-asserted-by":"crossref","first-page":"16348","DOI":"10.1073\/pnas.1205226109","article-title":"Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment","volume":"109","author":"Xu","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117239_b0280","first-page":"7454","volume":"6","author":"Puhl","year":"2021","journal-title":"Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine"},{"key":"10.1016\/j.bmc.2023.117239_b0285","first-page":"1733","article-title":"Redox active or thiol reactive?","volume":"27","author":"Proj","year":"2022","journal-title":"Optimization of rapid screens to identify less evident nuisance compounds, Drug Discov Today"},{"key":"10.1016\/j.bmc.2023.117239_b0290","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1039\/c3md00149k","article-title":"Chemical motifs that redox cycle and their associated toxicity","volume":"4","author":"Rana","year":"2013","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmc.2023.117239_b0295","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1021\/jm400568p","article-title":"Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II","volume":"56","author":"Raoof","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117239_b0300","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2017.12.017","article-title":"Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus","volume":"150","author":"Li","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2023.117239_b0305","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1128\/JVI.03050-13","article-title":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay","volume":"88","author":"Elshabrawy","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2023.117239_b0310","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.antiviral.2009.06.004","article-title":"Assay development and high-throughput antiviral drug screening against Bluetongue virus","volume":"83","author":"Li","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2023.117239_b0315","doi-asserted-by":"crossref","first-page":"e0007890","DOI":"10.1371\/journal.pntd.0007890","article-title":"Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection","volume":"13","author":"Lane","year":"2019","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:21:48Z","timestamp":1760836908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":63,"alternative-id":["S0968089623000871"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117239","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117239"}}